Početna stranicaDEVA • IST
add
Deva Holding AS
Preth. zaklj. cijena
66,95 ₺
Dnevni raspon
66,60 ₺ - 68,20 ₺
Godišnji raspon
51,00 ₺ - 81,75 ₺
Tržišna kapitalizacija
13,58 mlr. TRY
Prosječna količina
614,14 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
IST
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (TRY) | pro 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 5,49 mlr. | −2,19 % |
Operativni troškovi | 1,74 mlr. | 2,67 % |
Neto dohodak | −1,34 mlr. | −524,24 % |
Neto profitabilnost | −24,48 | −537,50 % |
Zarada po dionici | — | — |
EBITDA | 622,26 mil. | −48,71 % |
Efektivna porezna stopa | −294,28 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (TRY) | pro 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 3,59 mlr. | 26,49 % |
Ukupna imovina | 37,63 mlr. | −3,31 % |
Ukupne obveze | 11,31 mlr. | −3,14 % |
Ukupni kapital | 26,32 mlr. | — |
Dionice u optjecaju | 200,02 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,51 | — |
Povrat imovine | −0,61 % | — |
Povrat kapitala | −0,70 % | — |
Tok novca
Neto promjena novca
| (TRY) | pro 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | −1,34 mlr. | −524,24 % |
Gotovina od poslovanja | 1,49 mlr. | 27,32 % |
Gotovina iz ulaganja | −838,87 mil. | −130,98 % |
Gotovina iz financiranja | 260,62 mil. | 117,90 % |
Neto promjena novca | 885,62 mil. | 206,74 % |
Slobodan tok novca | −165,38 mil. | 95,31 % |
Više
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Osnovano
22. ruj 1958.
Web-lokacija
Zaposlenici
3.023
